WASHINGTON, June 27 -- Food and Drug Administration has issued a notice called: Medical Device User Fee Amendments; Stakeholder Meetings on the Medical Device User Fee Amendments of Fiscal Years 2028 to 2032 Reauthorization; Request for Notification of Stakeholder Intention To Participate.

The notice was published in the Federal Register on June 27 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or the Agency) is issuing this notice to request that public stakeholders-including patient and consumer advocacy groups, healthcare professionals, and scientific and academic experts-notify FDA of their intent to participate in periodic consultation meeting...